retatrutide phase 2 weight loss a 9-week trip on — LessWrong Retatrutide Phase 2: Type 2

She doesnt touch gluten, sugar or dairy

Many authors are mistaken when comparing trial results

Challenges around muscle loss, long-term adherence, durability of effect, and post-treatment weight regain are increasingly coming into focus

This can reduce the urge to snack and help control portion sizes

For UK patients, the most accurate expectation is: watch for approvals and rollout news in 2026 , but plan for realworld access to depend on MHRA decisions, supply, and NHS commissioning pathways

Current evidence suggests future protocols may include three stages: Initiation Phase 14 mg weekly 812 week metabolic adaptation Active Weight-Loss Phase 612 mg weekly 612 months Maintenance Phase 36 mg weekly If ongoing trials confirm early findings, retatrutide could become one of the most effective pharmacologic interventions for obesity ever developed